JnJ Surgery Robot Moves Closer to FDA Clinical Trials

According to a recent Medtech Insight article, Johnson & Johnson plans to submit its OTTAVA robotic surgical system for an investigational device exemption with the FDA. The submission is expected to happen in the second half of 2024 and will kickstart clinical trials for the system. The OTTAVA system uses four robotic arms on a standard surgical table, offering flexibility to surgeons during procedures. The arms can be repositioned without interrupting surgery, and they adapt to each patient's needs.